Items where Author is "Ball, GR"

ABDEL-FATAH, T.M.A., THANGAVELU, P.U., REID, L.E., MCCART REED, A.E., SAUNUS, J.M., DUIJF, P.H.G., SIMPSON, P.T., LAKHANI, S.R., BALL, G.R., PONGOR, L., GYORFFY, B., MOSELEY, P.M., GREEN, A.R., POCKLEY, A.G., CALDAS, C., ELLIS, I.O. and CHAN, S.Y.T., 2020. Association of sperm-associated antigen 5 and treatment response in patients With estrogen receptor–positive breast cancer. JAMA Network Open, 3 (7): e209486. ISSN 2574-3805

AL-JUBOORI, S.I.K., VADAKEKOLATHU, J., IDRI, S., WAGNER, S., ZAFEIRIS, D., PEARSON, J.R.D., ALMSHAYAKHCHI, R., CARAGLIA, M., DESIDERIO, V., MILES, A.K., BOOCOCK, D.J., BALL, G.R. and REGAD, T., 2019. PYK2 promotes HER2-positive breast cancer invasion. Journal of Experimental & Clinical Cancer Research, 38: 210. ISSN 1756-9966

WAGNER, S., VADAKEKOLATHU, J., TASIAN, S.K., ALTMANN, H., BORNHÄUSER, M., POCKLEY, A.G., BALL, G.R. and RUTELLA, S., 2019. A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study. Blood Advances, 3 (8), pp. 1330-1346. ISSN 2473-9529

VADAKEKOLATHU, J., AL-JUBOORI, S.I.K., JOHNSON, C., SCHNEIDER, A., BUCZEK, M.E., DI BIASE, A., POCKLEY, A.G., BALL, G.R., POWE, D.G. and REGAD, T., 2018. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell Death & Disease, 9: 344. ISSN 2041-4889

ZAFEIRIS, D., RUTELLA, S. and BALL, G.R., 2018. An artificial neural network integrated pipeline for biomarker discovery using Alzheimer's disease as a case study. Computational and Structural Biotechnology Journal, 16, pp. 77-87. ISSN 2001-0370

VADAKEKOLATHU, J., MEREDITH, R., ROSS, P.M., WAGNER, S., REEDER, S., DEMIRKAN, G., KUHAR, J.R., BALL, G.R., POCKLEY, A.G. and RUTELLA, S., 2017. Interferon-γ induces distinct mRNA and protein profiles in acute and chronic myeloid leukemia. Blood, 130 (Supp 1), 3945A. ISSN 0006-4971

ARORA, A., PARVATHANENI, S., ALESKANDARANY, M.A., AGARWAL, D., ALI, R., ABDEL-FATAH, T., GREEN, A.R., BALL, G.R., RAKHA, E.A., ELLIS, I.O., SHARMA, S. and MADHUSUDAN, S., 2017. Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers. Molecular Cancer Therapeutics, 16 (1), pp. 239-250. ISSN 1535-7163

ZAFEIRIS, D., VADAKEKOLATHU, J., WAGNER, S., POCKLEY, A.G., BALL, G.R. and RUTELLA, S., 2017. Discovery and application of immune biomarkers for hematological malignancies. Expert Review of Molecular Diagnostics, 17 (11), pp. 983-1000. ISSN 1473-7159

ABDEL-FATAH, T.M.A., REES, R.C., POCKLEY, A.G., MOSELEY, P., BALL, G.R., CHAN, S.Y.T., ELLIS, I.O. and MILES, A.K., 2017. The localisation of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2. Oncotarget, 8, pp. 112245-112257. ISSN 1949-2553

BAGNATI, M., OGUNKOLADE, B.W., MARSHALL, C., TUCCI, C., HANNA, K., JONES, T.A., BUGLIANI, M., NEDJAI, B., CATON, P.W., KIESWICH, J., YAQOOB, M.M., BALL, G.R., MARCHETTI, P., HITMAN, G.A. and TURNER, M.D., 2016. Glucolipotoxicity initiates pancreatic β-cell death through 1 tumour necrosis factor receptor 5 (TNFR5 / CD40) mediated 2 STAT1 and NF-κB activation. Cell Death and Disease, 7, e2329. ISSN 2041-4889

ABDEL-FATAH, T.M.A., AGARWAL, D., LIU, D.X., RUSSELL, R., RUEDA, O.M., LIU, K., XU, B., MOSELEY, P.M., GREEN, A.R., POCKLEY, A.G., REES, R.C., CALDAS, C., ELLIS, I.O., BALL, G.R. and CHAN, S.Y.T., 2016. SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. The Lancet Oncology, 17 (7), pp. 1004-1018. ISSN 1470-2045

ABDEL-FATAH, T.M.A., MCARDLE, S.E., AGARWAL, D., MOSELEY, P.M., GREEN, A.R., BALL, G.R., POCKLEY, A.G., ELLIS, I.O., REES, R.C. and CHAN, S.Y.T., 2016. HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis. Clinical Cancer Research, 22 (4), pp. 905-914. ISSN 1078-0432

GREEN, A.R., SORIA, D., STEPHENS, J., POWE, D.G., NOLAN, C.C., KUNKLER, I., THOMAS, J., KERR, G.R., JACK, W., CAMERON, D., PIPER, T., BALL, G.R., GARIBALDI, J.M., RAKHA, E.A., BARTLETT, J.M.S. and ELLIS, I.O., 2016. Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series. The Journal of Pathology: Clinical Research, 2 (1), pp. 32-40. ISSN 2056-4538

COVENEY, C., BOOCOCK, D.J., REES, R.C., DEEN, S. and BALL, G.R., 2015. Data mining of gene arrays for biomarkers of survival in ovarian cancer. Microarrays, 4 (3), pp. 324-338. ISSN 2076-3905

TONG, D.L., BALL, G.R. and POCKLEY, A.G., 2015. gEM/GANN: a multivariate computational strategy for auto-characterizing relationships between cellular and clinical phenotypes and predicting disease progression time using high-dimensional flow cytometry data. Cytometry Part A, 87 (7), pp. 616-623. ISSN 1552-4922

TONG, D.L., BOOCOCK, D.J., DHONDALAY, G.K.R., LEMETRE, C. and BALL, G.R., 2014. Artificial Neural Network Inference (ANNI): A Study on Gene-Gene Interaction for Biomarkers in Childhood Sarcomas. PLoS ONE, 9 (7), e102483. ISSN 1932-6203

ABDEL-FATAH, T.M.A., MCARDLE, S.E.B., JOHNSON, C., MOSELEY, P.M., BALL, G.R., POCKLEY, A.G., ELLIS, I.O., REES, R.C. and CHAN, S.Y.T., 2014. HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. British Journal of Cancer, 110 (10), pp. 2450-2461. ISSN 1532-1827

GREEN, A.R., POWE, D.G., RAKHA, E.A., SORIA, D., LEMETRE, C., NOLAN, C.C., BARROS, F.F.T., MACMILLAN, R.D., GARIBALDI, J.M., BALL, G.R. and ELLIS, I.O., 2013. Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. British Journal of Cancer, 109 (7), pp. 1886-1894. ISSN 0007-0920

LAVERSIN, S.A.-S., PHATAK, V.M., POWE, D.G., LI, G., MILES, A.K., HUGHES, D.C., BALL, G.R., ELLIS, I.O., GRITZAPIS, A.D., MISSITZIS, I., MCARDLE, S.E.B. and REES, R.C., 2013. Identification of novel breast cancer-associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells. Genes, Chromosomes and Cancer, 52 (3), pp. 316-329. ISSN 1098-2264

BAKER, B.G., BALL, G.R., RAKHA, E.A., NOLAN, C.C., CALDAS, C., ELLIS, I.O. and GREEN, A.R., 2013. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer. Breast Cancer Research and Treatment, 137 (1), pp. 127-137. ISSN 0167-6806

ALESKANDARANY, M.A., NEGM, O.H., RAKHA, E.A., AHMED, M.A.H., NOLAN, C.C., BALL, G.R., CALDAS, C., GREEN, A.R., TIGHE, P.J. and ELLIS, I.O., 2012. TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome. Breast Cancer Research and Treatment, 136 (2), pp. 419-427. ISSN 0167-6806

SHAABAN, A.M., BALL, G.R., BRANNAN, R.A., CSERNI, G., DI BENEDETTO, A., DENT, J., FULFORD, L., HONARPISHEH, H., JORDAN, L., JONES, J.L., KANTHAN, R., MARAQA, L., LITWINIUK, M., MOTTOLESE, M., POLLOCK, S., PROVENZANO, E., QUINLAN, P.R., REALL, G., SHOUSHA, S., STEPHENS, M., VERGHESE, E.T., WALKER, R.A., HANBY, A.M. and SPEIRS, V., 2012. A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Research and Treatment, 133 (3), pp. 949-958. ISSN 0167-6806

STORR, S.J., MOHAMMED, R.A.A., WOOLSTON, C.M., GREEN, A.R., PARR, T., SPITERI, I., CALDAS, C., BALL, G.R., ELLIS, I.O. and MARTIN, S.G., 2011. Calpastatin is associated with lymphovascular invasion in breast cancer. The Breast, 20 (5), pp. 413-418. ISSN 0960-9776

CHANG, K.H., MILLER, N., KHEIRELSEID, E.A.H., LEMETRE, C., BALL, G.R., SMITH, M.J., REGAN, M., MCANENA, O.J. and KERIN, M.J., 2011. MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. International Journal of Colorectal Disease, 26 (11), pp. 1415-1422. ISSN 0179-1958

TONG, D.L., BOOCOCK, D., COVENEY, C., SAIF, J., GOMEZ, S.G., QUEROL, S., REES, R. and BALL, G.R., 2011. A simpler method of preprocessing MALDI-TOF MS data for differential biomarker analysis: stem cell and melanoma cancer studies. Clinical Proteomics, 8 (1). ISSN 1542-6416

ZHANG, H., RAKHA, E.A., BALL, G.R., SPITERI, I., ALESKANDARANY, M., PAISH, E.C., POWE, D.G., MACMILLAN, R.D., CALDAS, C., ELLIS, I.O. and GREEN, A.R., 2010. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. Breast Cancer Research and Treatment, 121 (1), pp. 41-51. ISSN 0167-6806

LANCASHIRE, L.J., POWE, D.G., REIS-FILHO, J.S., RAKHA, E., LEMETRE, C., WEIGELT, B., ABDEL-FATAH, T.M., GREEN, A.R., MUKTA, R., BLAMEY, R., PAISH, E.C., REES, R.C., ELLIS, I.O. and BALL, G.R., 2010. A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks. Breast cancer research and treatment, 120 (1), pp. 83-93. ISSN 0167-6806

LEMETRE, C., LANCASHIRE, L.J., REES, R.C. and BALL, G.R., 2009. Artificial neural network based algorithm for biomolecular interactions modeling. In: J. CABESTANY, F. SANDOVAL, A. PRIETO and J.M. CORCHADO, eds., Bio-inspired systems: computational and ambient intelligence: 10th International Work-Conference on Artificial Neural Networks, IWANN 2009, Salamanca, Spain, June 10-12, 2009. Proceedings, Part I. Berlin: Springer, pp. 877-885. ISBN 9783642024771

ELSHEIKH, S.E., GREEN, A.R., RAKHA, E.A., POWE, D.G., AHMED, R.A., COLLINS, H.M., SORIA, D., GARIBALDI, J.M., PAISH, C.E., AMMAR, A.A., GRAINGE, M.J., BALL, G.R., ABDELGHANY, M.K., MARTINEZ-POMARES, L., HEERY, D.M. and ELLIS, I.O., 2009. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Research, 69 (9), pp. 3802-3809. ISSN 0008-5472

KAY, R.G., BARTON, C., VELLOSO, C.P., BROWN, P.R., BARTLETT, C., BLAZEVICH, A.J., GODFREY, R.J., GOLDSPINK, G., REES, R., BALL, G.R., COWAN, D.A., HARRIDGE, S.D., ROBERTS, J., TEALE, P. and CREASER, C.S., 2009. High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich α-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. Rapid Communications in Mass Spectrometry, 23 (19), pp. 3173-3182. ISSN 1097-0231

BALL, G.R., 2008. Computational & statistical methodologies to identify biomarkers in cancer. Current Cancer Therapy Reviews, 4 (2), pp. 157-160. ISSN 1573-3947

LANCASHIRE, L.J., REES, R.C. and BALL, G.R., 2008. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach. Artificial Intelligence in Medicine, 43 (2), pp. 99-111. ISSN 0933-3657

MURALI-GANESH, R., POWE, D.G., PANCHOLI, A., BALL, G.R., RAKHA, E. and ELLIS, I.O., 2007. ALCAM is an independent predictor of survival in unselected breast cancer. Ejc Supplements, 5 (3), pp. 28-29. ISSN 1359-6349

MITCHELL, M.J., WISHART, G., BLAMEY, R.W., BALL, G.R. and ELLIS, I.O., 2007. Absolute gain. Ejc Supplements, 5 (3), p. 35. ISSN 1359-6349

FINNEGAN, D.P., QUINN, M.F., HUMPHREYS, M., LAPPIN, T.R.J., MCMULLIN, M.F., THOMPSON, A. and BALL, G.R., 2007. Artificial neural network analysis identifies novel patterns of HOX gene expression in prognostic subgroups of acute myeloid leukaemia. British Journal of Haematology, 137, p. 67. ISSN 0007-1048

BLAMEY, R.W., MITCHELL, M.J., BALL, G.R., GREEN, A., RAMPAUL, R., PINDER, S., LEE, A., MACMILLAN, R.D. and ELLIS, I.O., 2007. Prognostic estimation: re-analysis of data from cases diagnosed in 1990-99 by Cox proportional hazards method. Ejc Supplements, 5 (3), p. 28. ISSN 1359-6349

BLAMEY, R.W., PINDER, S.E., BALL, G.R., ELLIS, I.O., ELSTON, C.W., MITCHELL, M.J. and HAYBITTLE, J.L., 2007. Reading the prognosis of the individual with breast cancer. European Journal of Cancer, 43 (10), pp. 1545-1547. ISSN 0959-8049

BLAMEY, R.W., ELLIS, I.O., PINDER, S.E., LEE, A.H.S., MACMILLAN, R.D., MORGAN, D.A.L., ROBERTSON, J.F.R., MITCHELL, M.J., BALL, G.R., HAYBITTLE, J.L. and ELSTON, C.W., 2007. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. European Journal of Cancer, 43 (10), pp. 1548-1555. ISSN 0959-8049

FINNEGAN, D.P.J., QUINN, M.F., HUMPHREYS, M., LAPPIN, T.R.J., MCMULLIN, M.F., THOMPSON, A. and BALL, G.R., 2006. Artificial neural NetworkAnalysis of HOX gene expression profiles predicts prognostic subgroups in acute myeloid leukemia. Blood, 108 (11). ISSN 0006-4971

LANCASHIRE, L.J., MIAN, S., REES, R.C. and BALL, G.R., 2003. Preliminary artificial neural network analysis of Seldi mass spectrometry data for the classification of melanoma tissue. In: D. AL-DABASS, ed., ESM 2003: 17Th European Simulation Multiconference - Foundations for Successful Modelling and Simulation. SCS Europe: Ghent, pp. 131-135. ISBN 3936150257

BALL, G.R., PALMER-BROWN, D., FUHRER, J., SKARBY, L., GIMENO, B.S. and MILLS, G., 2000. Identification of non-linear influences on the seasonal ozone dose-response of sensitive and resistant clover clones using artificial neural networks. Ecological Modelling, 129, pp. 153-168. ISSN 0304-3800

BALL, G.R., BENTON, J., PALMER-BROWN, D., FUHRER, J., SKARBY, L., GIMENO, B.S. and MILLS, G., 1998. Identifying factors which modify the effects of ambient ozone on white clover (Trifolium repens) in Europe. Environmental Pollution, 103 (1), pp. 7-16. ISSN 0269-7491

BALL, G.R., PALMER-BROWN, D., COBB, A.H. and SANDERS, G.E., 1995. Towards unravelling the complex interactions between microclimate, ozone dose, and ozone injury in clover. Water, Air, and Soil Pollution, 85 (3), pp. 1467-1472. ISSN 0049-6979